Back to search
FDAFDA · Food and drugs·Recall number D-418-2013

BUCALSEP (R) ORAL SOLUTION, (Benzocaine, 600 mg, Cetylpyridinum Chloride 30 mg, Menthol 45 mg Zinc Chloride 30 mg), 1 Fl. Oz. (30 mL), Manufactured for GIL PHARMACEUTICAL CORP, PONCE, PUERTO RICO 00717-1565 -- NDC 58552-103-01

Published May 22, 2013 · Recall initiated: April 8, 2013

Summary

FDA records drug Class III recall D-418-2013, published May 22, 2013 and initiated April 8, 2013. Recalling firm: Hi-Tech Pharmacal Co., Inc.; Status: Terminated; Reported quantity: 10,440 bottles; Lot: Lot 611614 (exp. 09/2013). Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent; Cetylpyridinum Chloride

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hi-Tech Pharmacal Co., Inc.
Distributor
Puerto Rico
Lot
Lot 611614 (exp. 09/2013)
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was BUCALSEP (R) ORAL SOLUTION, (Benzocaine, 600 mg, Cetylpyridinum Chloride 30 mg, Menthol 45 mg Zinc Chloride 30 mg), 1 Fl. Oz. (30 mL), Manufactured for GIL PHARMACEUTICAL CORP, PONCE, PUERTO RICO 00717-1565 -- NDC 58552-103-01 recalled?

Yes. FDA published recall D-418-2013 on May 22, 2013. Reported hazard: Subpotent; Cetylpyridinum Chloride

What should I do if I have this product?

Voluntary: Firm initiated · Letter